Explore our blog
Understanding the Medicare Part D Redesign Impact on Pharma: A Strategic Modeling Approach
Lou DeLoureiro | VP, Analytics Consulting Eve Jamali, MSc. | SVP, Managing Director, US Access Strategy & Analytics
The Inside Track on Market Access: 5 Trends Shaping Prescribing in 2025
How can we know what healthcare providers are really thinking about when it comes to cost, coverage, and patient access...
Navigating 340B and Rebates: Challenges, Solutions, and the Path Forward
Amy Martin, PharmD, BCPS | VP, Access Experience Team Angelica Norrell, PharmD, BCOP, CSP | Sr. Director, Access...